1. Home
  2. BOKF vs ALKS Comparison

BOKF vs ALKS Comparison

Compare BOKF & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BOK Financial Corporation

BOKF

BOK Financial Corporation

HOLD

Current Price

$134.53

Market Cap

8.0B

Sector

Finance

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$48.20

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOKF
ALKS
Founded
1910
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.5B
IPO Year
2007
2012

Fundamental Metrics

Financial Performance
Metric
BOKF
ALKS
Price
$134.53
$48.20
Analyst Decision
Hold
Buy
Analyst Count
9
14
Target Price
$133.67
$43.43
AVG Volume (30 Days)
249.2K
2.2M
Earning Date
04-20-2026
05-05-2026
Dividend Yield
1.91%
N/A
EPS Growth
12.65
N/A
EPS
2.58
N/A
Revenue
N/A
$1,475,899,000.00
Revenue This Year
$6.56
$24.26
Revenue Next Year
$5.22
$4.47
P/E Ratio
$51.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$96.89
$25.17
52 Week High
$139.73
$46.63

Technical Indicators

Market Signals
Indicator
BOKF
ALKS
Relative Strength Index (RSI) 58.41 78.79
Support Level $129.49 $27.65
Resistance Level $136.59 N/A
Average True Range (ATR) 2.54 1.66
MACD 0.46 0.17
Stochastic Oscillator 84.74 99.29

Price Performance

Historical Comparison
BOKF
ALKS

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: